Literature DB >> 12172950

Severe Henoch-Schönlein nephritis: resolution with azathioprine and steroids.

Surjit Singh1, Lata Kumar, Kusum Joshi, Ranjana W Minz, Usha Datta.   

Abstract

AIM: The aim of this study was to assess the efficacy of long-term azathioprine and steroids for treatment of severe nephritis in children with Henoch-Schönlein purpura (HSP).
METHODS: Analysis of case records of children with HSP followed up for a mean duration of 4.7 years (range 6 months-6.5 years) was performed. All underwent clinical status evaluation followed by percutaneous kidney biopsies. Renal histological changes were graded according to the International Study of Kidney Disease in Childhood (ISKDC) classification. Nine children with severe nephritis (grades III and IV) received steroids (mean duration 12.1 months) and long-term azathioprine (mean duration 14.7 months), while two children received steroids alone.
RESULTS: All nine children in the former category showed sustained clinical and biochemical remission, while the two children in the latter category did not.
CONCLUSION: Severe nephritis seen in association with HSP can be effectively treated with a combination of azathioprine and steroids.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172950     DOI: 10.1007/s00296-002-0208-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

1.  Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis.

Authors:  Salvatore Li Volti; Giovanni Li Volti
Journal:  Pediatr Nephrol       Date:  2003-09-12       Impact factor: 3.714

Review 2.  Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood.

Authors:  Marco Zaffanello; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

3.  Can azathioprine and steroids alter the progression of severe Henoch-Schönlein nephritis in children?

Authors:  Jae Il Shin; Jee Min Park; Youn Ho Shin; Ji Hong Kim; Jae Seung Lee; Pyung Kil Kim; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2005-05-12       Impact factor: 3.714

Review 4.  Off-label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics.

Authors:  Guo-Xiang Hao; Lin-Lin Song; Dong-Feng Zhang; Le-Qun Su; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

5.  Cyclosporin A therapy for severe Henoch-Schönlein nephritis with nephrotic syndrome.

Authors:  Jae Il Shin; Jee Min Park; Youn Ho Shin; Ji Hong Kim; Pyung Kil Kim; Jae Seung Lee; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

6.  Successful use of cyclosporin A in severe Schönlein-Henoch nephritis resistant to both methylprednisolone pulse and azathioprine.

Authors:  Jae Il Shin; Jee Min Park; Jae Seung Lee; Ji Hong Kim; Pyung Kil Kim; Hyeon Joo Jeong
Journal:  Clin Rheumatol       Date:  2006-04-14       Impact factor: 2.980

Review 7.  Systemic vasculitis in childhood.

Authors:  Abraham Gedalia; Raquel Cuchacovich
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

Review 8.  Henoch-Schönlein purpura.

Authors:  Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

9.  Primary Cutaneous Small Vessel Vasculitis.

Authors:  James P. Russell; Roger H. Weenig
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-04

Review 10.  Clinical approach to vasculitides.

Authors:  Surjit Singh; Rashna Dass
Journal:  Indian J Pediatr       Date:  2002-10       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.